Sandra Leung $BMY SEC Form 4 Insider Trading

Sandra Leung has filed a total of 2 insider trades in $BMY since 2021. Their most recent trade was a sale of 65,000 shares, made on Jun 06, 2022. Their largest trade was a sale of 65,000 shares, made on Jun 06, 2022. We estimate that they now own 457,732 shares of $BMY, worth an estimated $21.8 million.

Insider Trading at $BMY

There have been a total of 45 insider trades reported at $BMY since 2021, with 23,474 shares purchased and 1.4 million shares sold. The most active insider traders in $BMY stock have been Giovanni Caforio, Rupert Vessey, and David V Elkins. The most recent trade was a sale of 56,000 shares reported by David V Elkins (EVP, Chief Financial Officer), made on Sep 02, 2025.

$BMY Executives and Stock Owners with Insider Trades

• Giovanni Caforio, Board Chair and CEO

• Rupert Vessey, EVP, Research & Early Dev.

• David V Elkins, EVP, Chief Financial Officer

• Autenried Paul Von, EVP, Chief Information Officer

• Ann Powell, EVP, Chief Human Resources

• Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev.

• Christopher S. Boerner, Chief Executive Officer

• Sandra Leung, EVP, General Counsel

• Christopher S. Boerner, EVP, Chief Commercial Officer

• Benjamin Hickey, President, RayzeBio Org.

• Giovanni Caforio, Chairman and CEO

• Karen Murphy Santiago, SVP & Controller

• Phil M Holzer, SVP and Controller

• Rupert Vessey, EVP & President, Research

• Bartie Wendy Short, EVP, Corporate Affairs

• Robert M Plenge, EVP, Chief Research Officer

• Adam Dubow, SVP,ChiefCompliance&EthicsOff.

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.